Hyper Corporation

Hyper Corporation Depreciation & Amortization

The Depreciation & Amortization of Hyper Corporation (065650.KQ) as of Nov 4, 2026 is 1.23 B KRW. In the previous year, Depreciation & Amortization was 566.23 M KRW — a change of 117.68% (higher).

Depreciation & Amortization

1.23 BKRW

YoY

117.68%

Last updated:

Depreciation & Amortization of Hyper Corporation is 2024 1.23 B KRW. Depreciation & Amortization of Hyper Corporation was 2023 566.23 M KRW. It decreases by 117.68% higher compared to the previous year.

The Hyper Corporation Depreciation & Amortization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Depreciation & Amortization
Date
Depreciation & Amortization
Jan 1, 2017
11.00 M KRW
Jan 1, 2018
35.00 M KRW
Jan 1, 2019
44.00 M KRW
Jan 1, 2020
288.00 M KRW
Jan 1, 2021
701.38 M KRW
Jan 1, 2022
738.14 M KRW
Jan 1, 2023
566.23 M KRW
Jan 1, 2024
1.23 B KRW
The Hyper Corporation Depreciation & Amortization history
YEARDepreciation & AmortizationYoY
1.23 BKRW+117.68%
566.23 MKRW-23.29%
738.14 MKRW+5.24%
701.38 MKRW+143.54%
288.00 MKRW+554.55%
44.00 MKRW+25.71%
35.00 MKRW+218.18%
11.00 MKRW+22.22%
9.00 MKRW+12.50%
8.00 MKRW-89.61%
77.00 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hyper Corporation Stock analysis

What does Hyper Corporation do? Hyper Corporation Inc generates revenue through the Information Technology Business segment, which manufactures and sells mouses, monitors, televisions, routers, and game devices, while also operating Internet portals and specialized sites. The New Drug Business segment develops and sells non narcotic analgesics, Alzheimer's treatments, and Alzheimer's dementia diagnosis kits. The company's IT products are purchased by consumers and businesses seeking technology solutions, while the pharmaceutical products target healthcare providers and patients requiring pain management and cognitive health support. The Information Technology Business segment benefits from the sale of hardware devices and digital content services, with Internet portals and specialized sites driving user engagement and advertising revenue. The New Drug Business segment focuses on medical solutions for chronic conditions, serving both institutional and individual markets through direct sales channels. Both segments operate under the same corporate structure, leveraging the company's existing infrastructure for product development and distribution. Hyper Corporation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hyper Corporation stock

Depreciation & Amortization of Hyper Corporation is 1.23 B KRW in 2024.

Depreciation & Amortization of Hyper Corporation changed from 566.23 M KRW to 1.23 B KRW, representing a 117.68% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Depreciation & Amortization Hyper Corporation since 2006 – with annual values, charts, and detailed analysis.

Depreciation & Amortization represents the allocation of the cost of tangible and intangible assets over their useful lives.

Depreciation & Amortization's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Depreciation & Amortization's Hyper Corporation historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Hyper Corporation

All Key Metrics — Hyper Corporation